Obesity has become a global epidemic and major health problem in the 21st century. Dyslipidemia is one of the major metabolic consequences of obesity. Studies have shown that weight loss reduces elevated serum total cholesterol and low-density lipoprotein (LDL) cholesterol and increases high-density lipoprotein (HDL) cholesterol. Laparoscopic sleeve gastrectomy is one of the most recent ways to treat obesity and manage weight loss in overweight patients whose options for weight loss are limited. LSG was indicated as a definitive treatment in patients with BMI >40 kg/m2 or BMI >35 kg/m2 associated with co-morbidities.
AIM OF THE WORK
The aim of this study was to evaluate the short-term effect of laparoscopic sleeve gastrectomy on lipid profile in hyperlipidemic obese patients during the nine months of post - operative care.
PATIENTS AND METHODS:
This prospective study was conducted on 50 hyperlipidemic obese candidates of bariatric surgery at the Main University Hospital in Alexandria, Egypt from July 2020 to October 2021. Body weight, Body mass index (BMI), waist circumference, fasting and postprandial blood sugar, serum cholesterol, triglyceride, HDL and LDL levels were measured before and one, three, six and nine months following the surgical intervention.